![]() ![]() ![]() Improving this situation is of paramount importance to physicians.”Īccording to Pitre, OSA affects nearly one billion people in the world and puts many of them at risk of EDS. “Among those patients, many will have EDS, which affects their quality of life, making them less productive and also puts them at risk of other psychological issues. Many people have symptoms as the condition is highly associated with obesity, which affects a large and increasing number of people in Canada, the United States and other high-income countries,” added Pitre. “Fifteen to 30 per cent of people in North America have a diagnosis of OSA and the prevalence could be much higher as many others are undiagnosed. ![]() Tyler Pitre, study author and resident physician in internal medicine at McMaster University and incoming respirology fellow at the University of Toronto, suggests people with OSA should use their PAP machine first to treat EDS, and if they are still sleepy they can turn to medication for treatment. However, some people with OSA still experience EDS and may benefit from anti-fatigue medication. The standard treatment for OSA is a positive airway pressure (PAP) mask that uses compressed air to support lung airways during sleep. Their research was conducted from October 2022 to January 2023.ĮDS is when someone falls asleep or has a desire for sleep while expected to be awake, and it is often a symptom of sleep-related disorders. Their findings are based on a systematic review of 14 clinical trials of anti-fatigue medications involving 3,085 people, as well as analysing data from MEDLINE, CENTRAL, EMBASE and in a specific network meta-analysis. Our team will help you learn the skills needed to take control of the day-to-day management of your diabetes.Researchers from McMaster University have found what they call the “most effective” treatment for people with obstructive sleep apnea (OSA) who suffer from excessive daytime sleepiness (EDS).ĭena Zeraatkar and Tyler Pitre published their results in the peer-reviewed publication Annals of Internal Medicine, claiming the drug solriamfetol is “likely the best medication” for EDS. Patients attending the program also have opportunities to participate in a variety of international and national diabetes research studies, as well as locally initiated research projects that are testing new therapies and improve the care of people with diabetes. In the DCRP, services related to diabetes care include assessment, diagnosis, education, follow-up care, coaching, facilitation of physical activity, psychological assessment and therapy and the preparation and distribution of education materials. In 2018, the DCRP has been recognized by Diabetes Canada as meeting the standards outlined in the Diabetes Canada Standards Recognition Program. The DCRP also provides monthly information and education sessions to patients and families with a new diagnosis of diabetes, as well as mentorship and advice to other diabetes programs. This care is provided by an expert healthcare team. The DCRP provides seamless, integrated care for patients at risk of diabetes or diagnosed with type 1 or type 2 diabetes. The Diabetes Care and Research Program (DCRP) is an outpatient clinic, located within the Boris Clinic. ![]()
0 Comments
Leave a Reply. |